Ligand (LGND) Down 13.7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/02/20
Ligand Pharmaceuticals Management to Present at the H.C. Wainwright 22nd Annual Global Investment Virtual ConferenceBusiness Wire • 09/01/20
Ligand Commences Previously Announced Cash Tender Offer to Acquire Pfenex Inc.Business Wire • 08/31/20
Ligand Pharmaceuticals Shows Rising Relative Price Performance; Still Shy Of Key ThresholdInvestors Business Daily • 08/14/20
PFENEX ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PFNX and Encourages Investors to Contact the FirmBusiness Wire • 08/11/20
CStone Announces That OmniAb-derived CS1001 (Anti-PD-L1) Phase 3 Trial Met the Primary Endpoint as First-Line Treatment in Stage IV Squamous and Non-squamous Non-Small Cell Lung Cancer and Announces Plans to Submit a New Drug ApplicationBusiness Wire • 08/07/20
Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/03/20
Ligand Trounces Q2 Estimates by Helping Companies Make COVID-19 Drug RemdesivirThe Motley Fool • 08/03/20
Ligand Pharmaceuticals (LGND) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 08/03/20
Ligand Pharmaceuticals Shows Improved Relative Price Performance; Still Shy Of BenchmarkInvestors Business Daily • 06/03/20
Ligand Pharmaceuticals, Inc.'s (LGND) CEO John Higgins on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/07/20
Ligand Pharmaceuticals (LGND) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research • 05/06/20